Paushak Ltd Reports Robust Q1 FY27 Performance

Revenue from operations: ₹83.55 crore
Profit After Tax: ₹15.10 crore

Reader Takeaway: Strong revenue and profit growth driven by demand in speciality chemicals, while expense rise needs monitoring.

What just happened

Paushak Limited announced its financial results for the quarter ended June 30, 2026 (Q1 FY27). The company posted a significant year-on-year increase in both revenue and profitability. Revenue from operations climbed by 49.52% to ₹83.55 crore, up from ₹55.88 crore in the same period last year. Profit After Tax (PAT) also saw a healthy jump of 25.52%, reaching ₹15.10 crore compared to ₹12.03 crore in Q1 FY26. The basic and diluted Earnings Per Share (EPS) stood at ₹6.13 for the quarter.

Why this matters

This strong performance indicates significant growth for Paushak Limited, primarily driven by its Speciality Chemicals business. The substantial revenue increase suggests healthy demand for its products. Investors will be keen to see if the company can sustain this growth momentum and manage its expanding cost base effectively.

The backstory

Paushak Limited operates as a single reportable segment, exclusively focused on Speciality Chemicals. This focused approach allows for clear analysis of its performance within its chosen niche.

What changes now

The company's financial results show a positive trend, with strong top-line and bottom-line growth. Investors can take note of the significant increase in total expenses, which rose by 60.61% to ₹67.68 crore from ₹42.14 crore. Despite this, the revenue growth outpaced expense growth, leading to improved net profitability. The statutory auditors have provided an unmodified opinion on these financial results.

Risks to watch

While the revenue and profit growth are positive, investors should monitor the significant increase in total expenses. Sustaining profitability in future quarters will depend on the company's ability to manage these rising costs effectively.

Peer comparison

As Paushak operates in the speciality chemicals segment, its performance can be benchmarked against other chemical manufacturers. However, specific peer data is not provided in the filing.

Context metrics (time-bound)

• Q1 FY27 Revenue: ₹83.55 crore (up 49.52% YoY)
• Q1 FY27 PAT: ₹15.10 crore (up 25.52% YoY)
• Q1 FY27 EPS: ₹6.13
• Q1 FY27 Total Expenses: ₹67.68 crore (up 60.61% YoY)

What to track next

Investors should closely watch Paushak Limited's future quarterly results to see if this growth trajectory can be maintained. Monitoring the company's expense management and market positioning within the speciality chemicals sector will be crucial.